Medication selection for clinical treatment of COVID-19

ABSTRACT

The 2019 coronavirus disease(COVID-19), like most viral infections, has no specific medications and no targeted treatment besides vaccines. In clinic, medicinal treatment is mainly aimed at the harm that the immune system is activated to the limit or out of control after the patients are infected with the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). This study systematically reviewed clinical treatment of COVID-19 since its outbreak by combining the diagnosis and treatment plan for COVID-19 from First to Seventh Edition issued by the National Health Protection Commission of China. The strategy of selecting medication for treating COVID-19 is proposed and the efficacy and risk of various Western medications currently used in clinical practice were evaluated. The purpose of this study is to provide theoretical basis and clinical cases for clinicians in madication selection for Corona virus disease 2019(Covid-19) and severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).